-

Neogen Announces Board Transition with Appointment of Avi Pelossof and the Retirement of William Boehm

LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today that William Boehm has chosen to retire from the Company’s Board of Directors, effective October 23, 2025. Mr. Boehm has served on Neogen’s Board since 2011 and currently serves on the Compensation & Talent Management Committee and chairs the Audit Committee.

“On behalf of the entire Board and leadership team, I want to express our deep gratitude to Bill for his many years of dedicated service to Neogen,” said James C. Borel, Chair of the Neogen Board of Directors. “Bill’s insight, guidance, and commitment to our mission have been invaluable in shaping Neogen’s path forward. His contributions have strengthened our strategic direction and helped position the company for continued growth and long-term success.”

The Company is excited to announce that Avi Pelossof will join Neogen’s Board of Directors effective October 24, 2025.

Mr. Pelossof has over 25 years of experience in the diagnostics market. He most recently served as Chief Executive Officer, President, and a member of the Board of Directors at Immucor Inc., where he led the company’s turnaround and its acquisition by Werfen in 2023. He previously served as Global President, Infectious Disease at Alere Inc., where he built the business into a $750 million global portfolio and launched the first FDA CLIA-waived point-of-care molecular test, now marketed by Abbott as ID NOW.

“We are pleased to welcome Avi to Neogen’s Board,” said Mr. Borel. “His track record of leading complex organizations through transformation, combined with his deep sector expertise, will bring valuable insight and perspective to our Board’s work.”

“I’m thrilled to join Neogen’s Board,” said Mr. Pelossof. “This is an exciting time for the company, and I look forward to working with my fellow directors and leadership team to help drive innovation, growth, and lasting value for shareholders.”

For more information about Neogen’s Board of Directors, visit neogen.com.

About Neogen

Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.

Neogen Corporation

NASDAQ:NEOG

Release Versions

More News From Neogen Corporation

Neogen Announces First-Quarter Earnings Release Date

LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) will issue its first-quarter earnings release before the opening of the market on October 9, 2025. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time, to discuss the financial results. The conference call can be accessed by dialing: Toll-Free - North America: 1-800-549-8228 International: (+1) 646-564-2877 Conference ID: 49915 The live webcast can be acces...

Neogen® Announces CFO Transition Plan

LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, today announced that David Naemura, Chief Financial Officer and Chief Operating Officer, has communicated his intention to depart the Company. Mr. Naemura will continue to serve in his existing roles until his departure, which is expected to occur after the Company’s filing of its 10-Q in October, and no later than the end of 2025. Neogen has engaged a leading executive search fir...

Neogen® Establishes Relationship with Biomatter

LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today that it has entered into an arrangement with Biomatter, a leading enzyme design company, to leverage Biomatter’s proprietary Intelligent Architecture™ platform and Neogen’s expertise in the field of analytical development and technology to create new enzyme-based products. Biomatter’s Intelligent Architecture™ platform, based on AI and Physical modelling, enables t...
Back to Newsroom